ADMA Biologics Inc Cash Flow Quality Index
ADMA Biologics Inc cash flow quality index. ADMA Biologics Inc (ADMA) has a Cash Flow Quality Index of 0.78x as of June 2026. Operating cash flow of $29.54 Million is below net income of $37.82 Million, suggesting accrual-heavy earnings not yet converted to cash. See financial flexibility index of ADMA Biologics Inc to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of ADMA Biologics Inc (2024–2025)
Cash flow quality index of ADMA Biologics Inc from 2024 to 2025. Historical Cash Flow Quality Index for ADMA Biologics Inc across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore ADMA Biologics Inc (ADMA) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
ADMA Biologics Inc Cash Flow Quality Index by Year (2024–2025)
ADMA Biologics Inc cash flow quality index by year from 2024 to 2025. Year-by-year earnings quality comparison for ADMA Biologics Inc. For the full cash flow conversion analysis, see ADMA operating cash flow.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.34x | $50.40 Million | $146.93 Million | ▼ -42.9% |
| 2024 | 0.60x | $118.67 Million | $197.67 Million | — |